as 03-28-2025 4:00pm EST
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Founded: | 1901 | Country: | Israel |
Employees: | N/A | City: | TEL AVIV |
Market Cap: | 18.4B | IPO Year: | N/A |
Target Price: | $24.00 | AVG Volume (30 days): | 11.4M |
Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.45 | EPS Growth: | N/A |
52 Week Low/High: | $12.51 - $22.80 | Next Earning Date: | 05-07-2025 |
Revenue: | $16,544,000,000 | Revenue Growth: | 4.41% |
Revenue Growth (this year): | 5.31% | Revenue Growth (next year): | 1.18% |
TEVA Breaking Stock News: Dive into TEVA Ticker-Specific Updates for Smart Investing
Motley Fool
a day ago
GlobeNewswire
2 days ago
GlobeNewswire
2 days ago
Motley Fool
5 days ago
Insider Monkey
7 days ago
Investor's Business Daily
11 days ago
Simply Wall St.
11 days ago
PR Newswire
15 days ago
The information presented on this page, "TEVA Teva Pharmaceutical Industries Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.